INGALLS & SNYDER LLC - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 78 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
INGALLS & SNYDER LLC ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q1 2020$1,364,000
-3.3%
266,473
-13.8%
0.09%
+21.1%
Q4 2019$1,410,000
-24.0%
309,244
+2.0%
0.08%
-16.5%
Q3 2019$1,856,000
+2.3%
303,244
+1.7%
0.09%
+4.6%
Q2 2019$1,815,000
+9.1%
298,077
-0.5%
0.09%
+10.1%
Q1 2019$1,663,000
-7.5%
299,577
-5.7%
0.08%
-16.8%
Q4 2018$1,798,000
-43.7%
317,639
+4.4%
0.10%
-29.6%
Q3 2018$3,196,000304,3680.14%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,150,925$7,826,0002.91%
New Jersey Better Educational Savings Trust 158,000$1,074,0000.69%
ARS Investment Partners, LLC 620,936$4,222,0000.65%
PERKINS CAPITAL MANAGEMENT INC 68,050$463,0000.51%
First Light Asset Management, LLC 76,302$519,0000.23%
Kovack Advisors, Inc. 33,509$228,0000.11%
WHITE PINE CAPITAL LLC 32,625$222,0000.09%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 97,823$665,0000.06%
TAURUS ASSET MANAGEMENT, LLC 17,000$116,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 107,500$731,0000.01%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders